Among all known human disease diseasesmusculoskeletal system occupy a leading position. Today, virtually impossible to find a person older than 60 years who has not suffered from diseases of the musculoskeletal system. Age-related changes in musculoskeletal - musculoskeletal system are expressed in dystrophic and destructive processes in the spine, bones and ligaments of the joints, which often leads to disability rights. Unfortunately, in recent years there has been a trend towards the rejuvenation of these diseases.
This pathology is a significant part ofamong all occupational diseases. It has been established that the occupational diseases of the musculoskeletal system of physical overload observed in a variety of occupations in many industries. Most often they are marked with the builders, painters, textile workers, plumbers, drivers, athletes, and so on. D.
As a result, the large load, inflammatoryprocesses, the effects of trauma joints cartilage thins and breaks. For the treatment and prevention of joint lesions developed drugs - hondroprotektory example rumalon. Especially effective treatment in the early stages of the disease. The drug rumalon protects and restores joint cartilage. When using rumalon restored joint work, decreases pain, prevented further destruction of cartilage.
Rumalon Treatment is effective in osteoarthritis,gonarthrosis, coxarthrosis, arthrosis fingers spondyloarthrosis, spondylosis, osteochondrosis, chondromalacia patella. Also, the drug makes it easier for the disease by activating the synthesis of collagen and proteoglikonov included in the structure of the intervertebral disc and cartilage of joints, it causes a slowing of degenerative processes in the hyaline cartilage.
In addition, rumalon inhibits the activity of enzymes that cause the destruction of cartilage, increases the number of joint lubrication, improves nutrition of cartilage.
According to international and carried onRussian clinical drug research bases hondroprotekternogo rumalon action is highly effective and safe treatment for diseases of musculoskeletal system. The drug reduces the need for anti-inflammatory and analgesic drugs. According to many experts rumalon is the main base osteoarthritis therapy.
The research staff of the Institute of RheumatologyIt showed that treatment of patients with osteoarthritis by using rumalon gives a positive result. So, for 3 years at the Institute of Rheumatology, were treated 80 patients with osteoarthritis of the knee rumalon to 15 injections per course (total 30 ml of the drug). Such courses were held for 3, six and assessment of the results after the sixth year showed that rumalon has obvious analgesic effect, maintains and improves joint function and was well tolerated. (See Diagnosis and treatment of elderly patients suffering from osteoarthritis of the manifest; "breast cancer (Russian Medical Journal)", 1996; 4:.. 40-3 4. Mach ES features arthrosonography in rheumatology Wedge revmat, 1993;... 2:. 14-9 5. Nasonova VA, Ants Yu, Kuzmina NN)
Rumalon drug produced in Russia by ZAO "Bryntsalov-A", which has the exclusive right to manufacture the drug, transmitted by Robofarm, Switzerland.
Treatment with rumalon appointed doctor andIt is conducted under strict medical supervision. The solution is administered intramuscularly, starting with 0.3 ml volume, leading gradually to 1-2 ml. Injection is performed 2-3 times per week depending on the tolerance and disease severity. The best course of 6-8 weeks 2 times a year.
For patients with diseases of musculoskeletal system CJSC "Bryntsalov-A" opened a consultative and treatment room artroterapii rumalon.
The office artroterapii you can get treatment and advice the doctor for free, paying only the cost of the drug at the price of the manufacturer.
Pensioners receive treatment free of charge.
For information call. 8-499-611-54-91 and 8-499-611-15-95.
More information can be found on the official website of the product.